A facile nanoparticle immunoassay for cancer biomarker discovery

Journal of Nanobiotechnology

Volumn 9, Issue , 2011, Pages

  Huo, Qun ^a   Colon, Jimmie ^b   Cordero, Adam ^a   Bogdanovic, Jelena ^a   Baker, Cheryl H ^b   Goodison, Steven ^b   Pensky, Marianna Y ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER BIOMARKERS; GENERAL TOOLS; GOLD NANOPARTICLE; HEALTHY CONTROLS; HUMAN BLOODS; HUMAN DISEASE; HUMAN SERUM; MALIGNANT CANCERS; MICE MODELS; MOUSE IGG; NANOPARTICLE SURFACE; PROSTATE CANCER DETECTION; PROSTATE CANCERS; SCREEN AND ANALYZE; SERUM PROTEINS; SERUM SAMPLES; SURFACE PLASMONS; TARGET PROTEINS; TUMOR ANGIOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANTIBODIES; BIOMARKERS; BODY FLUIDS; DYNAMIC LIGHT SCATTERING; IMMUNOLOGY; MAMMALS; NANOPARTICLES;

DISEASES;

BIOLOGICAL MARKER; GOLD NANOPARTICLE; IMMUNOGLOBULIN G; TUMOR MARKER; VASCULOTROPIN; GOLD; METAL NANOPARTICLE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DYNAMIC LIGHT SCATTERING; FACILE NANOPARTICLE IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; LIGHT SCATTERING; MALE; MOUSE; NONHUMAN; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ANIMAL; BLOOD; CHEMISTRY; PROSTATE TUMOR;

MUS;

ANIMALS; GOLD; HUMANS; IMMUNOASSAY; MALE; METAL NANOPARTICLES; MICE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 79956190431     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-9-20     Document Type: Article

References (33)

1. Yguerabide J, Yguerabide EE. Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. Anal Biochem 1998, 262:137-156. 10.1006/abio.1998.2759, 9750128.
2. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006, 110:7238-7248. 10.1021/jp057170o, 16599493.
3. Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou J, Chen H, Huo Q. A One-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc 2008, 130:2780-2782. 10.1021/ja711298b, 18257576.
4. Dai Q, Liu X, Coutts J, Austin L, Huo Q. A one-step highly sensitive method for DNA detection using dynamic light scattering. J Am Chem Soc 2008, 130:8138-8139. 10.1021/ja801947e, 18540598.
5. Jans H, Liu X, Austin L, Maes G, Huo Q. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding study. Anal Chem 2009, 81:9425-9432. 10.1021/ac901822w, 19803497.
6. Austin L, Liu X, Huo Q. An immunoassay for monoclonal antibody isotyping and quality analysis using gold nanoparticles and dynamic light scattering. American Biotechnology Laboratory 2010, 28:10-12. 8.
7. Bogdanovic J, Colon J, Baker C, Huo Q. A label-free nanoparticle aggregation assay for protein complex/aggregate detection and analysis. Anal Biochem 2010, 45:96-102.
8. Huo Q. Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation assay. Colloids Surfaces B 2010, 78:259-265.
9. Jaganathan S, Yue P, Paladino DC, Bogdanovic J, Huo Q, Turkson J. A functional nuclear epidermal growth factor receptor, Src and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One 2011, 6(5):e19605. 10.1371/journal.pone.0019605, 3088706, 21573184.
10. Xie H, Gill-Sharp KL, O'Neal DP. Quantitative estimation of gold nanoshell concentration in whole blood using dynamic light scattering. Nanomedicine NBM 2007, 3:89-94.
11. Yang X, Huang J, Wang Q, Wang K, Yang L, Huo X. A one-step sensitive dynamic light scattering method for adenosine detection using split aptamer fragments. Anal Method 2011, 3:59-61.
12. Kalluri JR, Arbneshi T, Khan SA, Nelly A, Candice P, Varisli B, Washington M, McAfee S, Robinson B, Banerjee S, Singh AK, Senapati D, Ray PC. Use of gold nanoparticles in a simple colorimetric and ultrasensitive dynamic light scattering assay: selective detection of arsenic in groundwater. Angew Chem Int Ed 2009, 48:9668-9671.
13. Dasary SSR, Senapati D, Singh AK, Anjaneyulu Y, Yu H, Ray PC. Highly sensitive and selective dynamic light scattering assay for TNT detection using p-ATP attached gold nanoparticles. ACS Appl Mater Interfaces 2010, 2:3455-3460. 10.1021/am1005139, 21077646.
14. Bega L, Singh AK, Senapati D, Arumugam SR, Ray PC. Gold nanoparticle-based simple colorimetric and ultrasensitive dynamic light scattering assay for the selective detection of Pb(II) from paints, plastics, and water samples. ACS Appl Mater Interfaces 2011, 3:668-673. 10.1021/am101118h, 21306127.
15. Miao X, Ling L, Shuai X. Ultrasensitive detection of lead(II) with DNAzyme and gold nanoparticle probes by using a dynamic light scattering technique. Chem Commun 2011, 47:4192-4194.
16. Berne BJ, Pecora R. Dynamic Light Scattering: with Applications to Chemistry, Biology, and Physics 1976, New York, Wiley.
17. Luchter-Wasylewska E, Wasylewski M, Röhm K-H. Concentration dependent dissociation association of human prostatic acid phosphatase. J Protein Chem 2003, 22:243-247. 10.1023/A:1025016402860, 12962324.
18. Luchter-Wasylewska E. Cooperative kinetics of human prostatic acid phosphatase. Biochim Biophys Acta 2001, 36470:1-8.
19. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine NBM 2009, 5:106-117.
20. Kaighn ME, Narayan KS, Ohnuki Y, Lechner J, Jones LW. Establishment of a human prostate cancer cell line (PC-3). Invest Urol 1979, 17:16-23.
21. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Ming-Chu T, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43:1809-1818.
22. Rembrink K, Romijn JC, van der Kwast TH, Rübben H, Schröder FH. Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer. The Prostate 1997, 31:168-174. 10.1002/(SICI)1097-0045(19970515)31:3<168::AID-PROS4>3.0.CO;2-H, 9167768.
23. Folkman J, Klasburn M. Angiogenic factors. Science 1987, 235:442-447. 10.1126/science.2432664, 2432664.
24. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8. 10.1056/NEJM199101033240101, 1701519.
25. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996, 32A:2413-2422.
26. Park JE, Keller GA, Ferrara N. The vascular endothelia growth factor isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993, 4:1317-1326. 275767, 8167412.
27. Rennel ES, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, Sugiono M, Gillatt D, Kleinerman ES, Bates DO, Harper SJ. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumor growth in mice. British J Cancer 2008, 98:1250-1250.
28. George ML, Tutton MG, Janssen F, Arnaoutz A, Abulafi AM, Eccles SA, Swift RI. VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression. Neoplasia 2001, 3:420-427. 10.1038/sj.neo.7900186, 1506210, 11687953.
29. Refer to product information from Refer to product information from., http://www.abcam.com
30. Diamandis EP, Fritsche HA, Lilja H, Chan DW, Schwartz MK. Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications 2002, Washington, DC, American Association for Clinical Chemistry.
31. Aragon-Ching JB, Dahut WL. VEGF inhibitors and prostate cancer therapy. Curr Mol Pharmacol 2009, 2:161-168. 2711630, 19617926.
32. Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 2000, 60:2898-2905.
33. Botelho F. VEGF and prostate cancer: a systematic review. Eur J Cancer Prevention 2010, 19:385-392.